vs
A.O.史密斯（AOS）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
A.O.史密斯的季度营收约是ICU MEDICAL INC的1.7倍（$945.6M vs $540.7M），A.O.史密斯净利率更高（12.5% vs -2.9%，领先15.4%），A.O.史密斯同比增速更快（-2.0% vs -14.1%），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -3.9%）
A.O.史密斯是美国知名的家用及商用热水器、锅炉生产商，也是北美规模最大的热水器制造销售商，在亚洲市场还供应水处理和净化产品。公司在全球共有27个站点，包括北美5座生产基地，以及位于印度班加罗尔、中国南京、荷兰费尔德霍芬的工厂。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
AOS vs ICUI — 直观对比
营收规模更大
AOS
是对方的1.7倍
$540.7M
营收增速更快
AOS
高出12.1%
-14.1%
净利率更高
AOS
高出15.4%
-2.9%
两年增速更快
ICUI
近两年复合增速
-3.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $945.6M | $540.7M |
| 净利润 | $118.0M | $-15.7M |
| 毛利率 | 38.7% | 37.5% |
| 营业利润率 | — | 1.0% |
| 净利率 | 12.5% | -2.9% |
| 营收同比 | -2.0% | -14.1% |
| 净利润同比 | -14.0% | 34.0% |
| 每股收益（稀释后） | $0.85 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AOSICUI
| Q1 26 | $945.6M | — | ||
| Q4 25 | $912.5M | $540.7M | ||
| Q3 25 | $942.5M | $537.0M | ||
| Q2 25 | $1.0B | $548.9M | ||
| Q1 25 | $963.9M | $604.7M | ||
| Q4 24 | $912.4M | $629.8M | ||
| Q3 24 | $902.6M | $589.1M | ||
| Q2 24 | $1.0B | $596.5M |
净利润AOSICUI
| Q1 26 | $118.0M | — | ||
| Q4 25 | $125.4M | $-15.7M | ||
| Q3 25 | $132.0M | $-3.4M | ||
| Q2 25 | $152.2M | $35.3M | ||
| Q1 25 | $136.6M | $-15.5M | ||
| Q4 24 | $109.7M | $-23.8M | ||
| Q3 24 | $120.1M | $-33.0M | ||
| Q2 24 | $156.2M | $-21.4M |
毛利率AOSICUI
| Q1 26 | 38.7% | — | ||
| Q4 25 | 38.4% | 37.5% | ||
| Q3 25 | 38.7% | 37.4% | ||
| Q2 25 | 39.3% | 37.9% | ||
| Q1 25 | 38.9% | 34.7% | ||
| Q4 24 | 37.1% | 36.1% | ||
| Q3 24 | 37.4% | 34.8% | ||
| Q2 24 | 38.7% | 34.8% |
营业利润率AOSICUI
| Q1 26 | — | — | ||
| Q4 25 | 17.9% | 1.0% | ||
| Q3 25 | 18.6% | 2.6% | ||
| Q2 25 | 20.4% | 1.9% | ||
| Q1 25 | 19.1% | 2.1% | ||
| Q4 24 | 10.1% | 6.0% | ||
| Q3 24 | 19.5% | 1.4% | ||
| Q2 24 | 21.9% | 1.3% |
净利率AOSICUI
| Q1 26 | 12.5% | — | ||
| Q4 25 | 13.7% | -2.9% | ||
| Q3 25 | 14.0% | -0.6% | ||
| Q2 25 | 15.0% | 6.4% | ||
| Q1 25 | 14.2% | -2.6% | ||
| Q4 24 | 12.0% | -3.8% | ||
| Q3 24 | 13.3% | -5.6% | ||
| Q2 24 | 15.2% | -3.6% |
每股收益（稀释后）AOSICUI
| Q1 26 | $0.85 | — | ||
| Q4 25 | $0.89 | $-0.63 | ||
| Q3 25 | $0.94 | $-0.14 | ||
| Q2 25 | $1.07 | $1.43 | ||
| Q1 25 | $0.95 | $-0.63 | ||
| Q4 24 | $0.75 | $-0.97 | ||
| Q3 24 | $0.82 | $-1.35 | ||
| Q2 24 | $1.06 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.2M | — |
| 总债务越低越好 | $574.2M | — |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $3.7B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资AOSICUI
| Q1 26 | $185.2M | — | ||
| Q4 25 | $193.2M | — | ||
| Q3 25 | $172.8M | — | ||
| Q2 25 | $177.9M | — | ||
| Q1 25 | $200.2M | — | ||
| Q4 24 | $276.1M | $308.6M | ||
| Q3 24 | $255.6M | $312.5M | ||
| Q2 24 | $233.3M | $302.6M |
总债务AOSICUI
| Q1 26 | $574.2M | — | ||
| Q4 25 | $155.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $193.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AOSICUI
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $1.8B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.9B | $2.0B | ||
| Q3 24 | $1.9B | $2.0B | ||
| Q2 24 | $1.9B | $2.0B |
总资产AOSICUI
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.1B | $4.1B | ||
| Q3 25 | $3.2B | $4.1B | ||
| Q2 25 | $3.2B | $4.1B | ||
| Q1 25 | $3.3B | $4.2B | ||
| Q4 24 | $3.2B | $4.2B | ||
| Q3 24 | $3.2B | $4.3B | ||
| Q2 24 | $3.2B | $4.3B |
负债/权益比AOSICUI
| Q1 26 | 0.31× | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | 1.1% | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流AOSICUI
| Q1 26 | — | — | ||
| Q4 25 | $183.1M | $60.6M | ||
| Q3 25 | $255.4M | $56.7M | ||
| Q2 25 | $139.6M | $11.2M | ||
| Q1 25 | $38.7M | $51.3M | ||
| Q4 24 | $221.9M | $40.2M | ||
| Q3 24 | $195.9M | $36.1M | ||
| Q2 24 | $57.4M | $82.0M |
自由现金流AOSICUI
| Q1 26 | — | — | ||
| Q4 25 | $165.5M | $36.0M | ||
| Q3 25 | $240.6M | $27.6M | ||
| Q2 25 | $122.5M | $-8.5M | ||
| Q1 25 | $17.4M | $36.7M | ||
| Q4 24 | $191.3M | $16.1M | ||
| Q3 24 | $163.4M | $16.2M | ||
| Q2 24 | $34.5M | $62.5M |
自由现金流率AOSICUI
| Q1 26 | — | — | ||
| Q4 25 | 18.1% | 6.6% | ||
| Q3 25 | 25.5% | 5.1% | ||
| Q2 25 | 12.1% | -1.5% | ||
| Q1 25 | 1.8% | 6.1% | ||
| Q4 24 | 21.0% | 2.6% | ||
| Q3 24 | 18.1% | 2.7% | ||
| Q2 24 | 3.4% | 10.5% |
资本支出强度AOSICUI
| Q1 26 | 1.1% | — | ||
| Q4 25 | 1.9% | 4.6% | ||
| Q3 25 | 1.6% | 5.4% | ||
| Q2 25 | 1.7% | 3.6% | ||
| Q1 25 | 2.2% | 2.4% | ||
| Q4 24 | 3.4% | 3.8% | ||
| Q3 24 | 3.6% | 3.4% | ||
| Q2 24 | 2.2% | 3.3% |
现金转化率AOSICUI
| Q1 26 | — | — | ||
| Q4 25 | 1.46× | — | ||
| Q3 25 | 1.93× | — | ||
| Q2 25 | 0.92× | 0.32× | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 0.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOS
暂无分部数据
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
